Figure 5.Kaplan-Meier analysis in the training, validation and whole cohorts according to the lncRNA-based classifiers stratified by clinicopathological risk factors. (A–C) Kaplan-Meier survival curves of LIHC patients with combinations of lncRNA-classifier and TNM T classifier in the training, test and TCGA cohorts for OS; (D–F) Kaplan-Meier survival curves of LIHC patients with combinations of lncRNA-classifier and TNM stage in the training, test and TCGA cohorts for OS. lncRNA, long non-coding RNA; OS, overall survival; LIHC, Liver hepatocellular carcinoma.
